Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fuller

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
Head & Neck|January 11, 2025
Exploring Quantitative MRI Biomarkers of Head and Neck Post-Radiation Lymphedema and Fibrosis: Post Hoc Analysis of a Prospective Trial, Shitong Mao, Jihong Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2020
Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancerStephen R Grant, Katherine A Hutcheson, Rong Ye, et al.
The Oncologist|April 10, 2020
Exclusion of Men from Randomized Phase III Breast Cancer Clinical TrialsKelsey L Corrigan, Walker Mainwaring, Austin B Miller, et al.
International Journal of Cancer|August 14, 2024
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trialsAlexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
International Journal of Particle Therapy|July 21, 2021
Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal CancerNikhil G Thaker, David Boyce-Fappiano, Matthew S Ning, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2021
The radiotherapy quality assurance gap among phase III cancer clinical trialsKelsey L Corrigan, Stephen Kry, Rebecca M Howell, et al.
Cancer|January 17, 2018
Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapyMona Kamal, Abdallah S R Mohamed, Clifton David Fuller, et al.
JAMA Oncology|April 26, 2019
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 TrialQuynh-Nhu Nguyen, Stephen G Chun, Edward Chow, et al.
Seminars in Radiation Oncology|May 9, 2018
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to ActivationSteven J Frank, Pierre Blanchard, J Jack Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Early Imaging Identification of Osteoradionecrosis and Classification Using the Novel ClinRad System: Results from A Retrospective Observational Cohort, Jillian Rigert, Zaphanlene Kaffey, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
Head & Neck|January 11, 2025
Exploring Quantitative MRI Biomarkers of Head and Neck Post-Radiation Lymphedema and Fibrosis: Post Hoc Analysis of a Prospective Trial, Shitong Mao, Jihong Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2020
Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancerStephen R Grant, Katherine A Hutcheson, Rong Ye, et al.
The Oncologist|April 10, 2020
Exclusion of Men from Randomized Phase III Breast Cancer Clinical TrialsKelsey L Corrigan, Walker Mainwaring, Austin B Miller, et al.
International Journal of Cancer|August 14, 2024
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trialsAlexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
International Journal of Particle Therapy|July 21, 2021
Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal CancerNikhil G Thaker, David Boyce-Fappiano, Matthew S Ning, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2021
The radiotherapy quality assurance gap among phase III cancer clinical trialsKelsey L Corrigan, Stephen Kry, Rebecca M Howell, et al.
Cancer|January 17, 2018
Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapyMona Kamal, Abdallah S R Mohamed, Clifton David Fuller, et al.
JAMA Oncology|April 26, 2019
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 TrialQuynh-Nhu Nguyen, Stephen G Chun, Edward Chow, et al.
Seminars in Radiation Oncology|May 9, 2018
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to ActivationSteven J Frank, Pierre Blanchard, J Jack Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Early Imaging Identification of Osteoradionecrosis and Classification Using the Novel ClinRad System: Results from A Retrospective Observational Cohort, Jillian Rigert, Zaphanlene Kaffey, et al.
Pageof 20